Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 6,138 | 44,789 | 143,161 | 294,547 | 659,690 |
| Cost of Goods | 7,255 | 47,193 | 60,653 | 103,986 | 233,330 |
| Gross Profit | -1,117 | -2,404 | 82,508 | 190,561 | 426,360 |
| Operating Expenses | 190,549 | 662,885 | 305,242 | 376,674 | 454,796 |
| Operating Income | -191,411 | -665,096 | -222,081 | -185,127 | -28,106 |
| Interest Expense | 49,411 | 48,564 | 44,463 | 37,092 | 15,701 |
| Other Income | -45,282 | 9,389 | 287,121 | 57,690 | 41,679 |
| Pre-tax Income | -286,104 | -704,271 | 20,577 | -164,529 | -2,128 |
| Income Tax | -50,888 | -96,576 | 67 | -29,733 | -2,309 |
| Net Income Continuous | -235,216 | -607,695 | 20,510 | -134,796 | 181 |
| Net Income Discontinuous | 112,060 | -100,678 | -139,682 | -217,950 | -32,529 |
| Minority Interests | N/A | N/A | -54 | 10 | -138 |
| Net Income | $-123,156 | $-708,373 | $-119,118 | $-352,756 | $-32,210 |
| EPS Basic Total Ops | -1.68 | -9.79 | -1.71 | -5.28 | -0.50 |
| EPS Basic Continuous Ops | -3.20 | -8.40 | 0.29 | -2.02 | 0.00 |
| EPS Basic Discontinuous Ops | 1.52 | -1.39 | -2.00 | -3.26 | -0.50 |
| EPS Diluted Total Ops | -1.68 | -9.79 | -1.63 | -5.28 | -0.49 |
| EPS Diluted Continuous Ops | -3.20 | -8.40 | 0.28 | -2.02 | 0.00 |
| EPS Diluted Discontinuous Ops | 1.52 | -1.39 | -1.91 | -3.26 | -0.49 |
| EPS Diluted Before Non-Recurring Items | -2.91 | -8.40 | -1.71 | -3.32 | -0.50 |
| EBITDA(a) | $-163,525 | $-616,254 | $-164,857 | $-126,614 | $18,212 |